These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 20009294

  • 1. Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma.
    Prasanna VK, Venkataramana NK, Dwarakanath BS, Santhosh V.
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S44-7. PubMed ID: 20009294
    [Abstract] [Full Text] [Related]

  • 2. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
    Dwarakanath BS, Singh D, Banerji AK, Sarin R, Venkataramana NK, Jalali R, Vishwanath PN, Mohanti BK, Tripathi RP, Kalia VK, Jain V.
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S21-6. PubMed ID: 20009289
    [Abstract] [Full Text] [Related]

  • 3. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T, Jain V.
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.
    Gupta S, Farooque A, Adhikari JS, Singh S, Dwarakanath BS.
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S16-20. PubMed ID: 20009287
    [Abstract] [Full Text] [Related]

  • 5. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD, Flickinger JC, Larson D.
    Oncologist; 1997 Sep; 2(1):59-61. PubMed ID: 10388030
    [Abstract] [Full Text] [Related]

  • 6. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK, Prabhakara S, Narayanan V.
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [Abstract] [Full Text] [Related]

  • 7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

  • 8. Gd-Tex Pharmacyclics Inc.
    Radford IR.
    Curr Opin Investig Drugs; 2000 Dec 01; 1(4):524-8. PubMed ID: 11249709
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R, Dwarakanath B, Jain V.
    Int J Radiat Biol; 2005 May 01; 81(5):397-408. PubMed ID: 16076755
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO.
    Cancer J Sci Am; 1998 May 01; 4(6):364-9. PubMed ID: 9853135
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
    Kalia VK, Devi NK.
    Indian J Exp Biol; 1994 Sep 01; 32(9):637-42. PubMed ID: 7814043
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
    Kalia VK.
    Indian J Exp Biol; 1993 Apr 01; 31(4):312-5. PubMed ID: 8359829
    [Abstract] [Full Text] [Related]

  • 15. Hyperthermia--its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors.
    Seegenschmiedt MH, Feldmann HJ, Wust P, Molls M.
    Strahlenther Onkol; 1995 Oct 01; 171(10):560-72. PubMed ID: 8571175
    [Abstract] [Full Text] [Related]

  • 16. Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
    Farooque A, Afrin F, Adhikari JS, Dwarakanath BS.
    J Cancer Res Ther; 2009 Sep 01; 5 Suppl 1():S32-5. PubMed ID: 20009291
    [Abstract] [Full Text] [Related]

  • 17. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D, Chandna S, Dwarakanath SB.
    J Cancer Res Ther; 2009 Sep 01; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
    Dwarakanath BS.
    J Cancer Res Ther; 2009 Sep 01; 5 Suppl 1():S27-31. PubMed ID: 20009290
    [Abstract] [Full Text] [Related]

  • 19. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE.
    Strahlenther Onkol; 2006 Jul 01; 182(7):400-7. PubMed ID: 16826359
    [Abstract] [Full Text] [Related]

  • 20. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):143-9. PubMed ID: 8832007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.